Related Experiment Video
Updated: Jul 14, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Progress and prospects: RNA-based therapies for treatment of HIV infection
L Scherer1, J J Rossi, M S Weinberg
1Division of Molecular Biology, City of Hope Beckman Research Institute, Duarte, CA 91010, USA.
Abstract:
The current treatment regimen for HIV-infected individuals combines two or more drugs targeting different viral proteins such as RT and gag. Resistance to conventional drugs can develop quickly, and typically persists. The prospect of longer, continuous antiretroviral therapy brings with it the need for new antiretroviral drugs and approaches. In this context, gene therapies have the potential to prolong life and quality of life as an additional therapeutic class and may serve as an adjuvant to traditional treatments. This review focuses on RNA-based hematopoietic cell gene therapy for treatment of HIV infection. Recent advances in our understanding of RNA interference (RNAi) make this an especially attractive candidate for anti-HIV gene therapy although ribozyme and RNA decoy/aptamer approaches can be combined with RNAi to make a combinatorial therapy akin to highly active anti-retroviral therapy.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Microorganisms in Medicine and Therapeutics
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

